The blood grouping reagents market size per capita in Spain is projected to see incremental growth from USD 2.18 in 2024 to USD 2.34 by 2028. This shows a continuation of the upward trend observed from earlier years. In 2023, the market stood at USD 2.15 per capita, affirming a steady year-on-year increase. Year-on-year variations have been moderate, with a relatively stable increase of approximately 2% annually. The compounded annual growth rate (CAGR) over the last five years is indicative of consistent demand and market expansion.
Future trends to watch for include advancements in blood testing technologies, regulatory changes, and the potential impact of digital health innovations. These factors could further drive the market value per capita, enhancing efficiency and accessibility in blood grouping procedures in Spain.
